Medication-Related Fall Incidents in an Older, Ambulant Population: The B-PROOF Study

Drugs and Aging

Volumn 31, Issue 12, 2014, Pages 917-927

  Ham, Annelies C ^a   Swart, Karin M A ^b   Enneman, Anke W ^a   van Dijk, Suzanne C ^a   Oliai Araghi, Sadaf ^a   van Wijngaarden, Janneke P ^c   van der Zwaluw, Nikita L ^c   Brouwer Brolsma, Elske M ^c   Dhonukshe Rutten, Rosalie A M ^c   van Schoor, Natasja M ^b   van der Cammen, Tischa J M ^a   Lips, Paul ^b   de Groot, Lisette C P G M ^c   Uitterlinden, André G ^a   Witkamp, Renger F ^c   Stricker, Bruno H ^a   van der Velde, Nathalie ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANGIOTENSIN; ANGIOTENSIN II ANTAGONIST; ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARDIAC GLYCOSIDE; CARDIOVASCULAR AGENT; CHOLINESTERASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC AGENT; LOOP DIURETIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VASODILATOR AGENT; ANTIARRHYTHMIC AGENT;

AGED; ARTICLE; COMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG USE; FALL RISK; FALLING; FEMALE; FOLLOW UP; GRIP STRENGTH; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PHYSICAL PERFORMANCE; PRESCRIPTION; PROSPECTIVE STUDY; WALKING AID; ELDERLY CARE; HIP FRACTURES; INCIDENCE; INDEPENDENT LIVING; NETHERLANDS; PREVENTION AND CONTROL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; BENZODIAZEPINES; FEMALE; HEALTH SERVICES FOR THE AGED; HIP FRACTURES; HUMANS; INCIDENCE; INDEPENDENT LIVING; MALE; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84911969541     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-014-0225-x     Document Type: Article

References (48)

1. Cumming RG. Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging. 1998;12(1):43–53.
2. Tinetti ME, Doucette J, Claus E, et al. Risk factors for serious injury during falls by older persons in the community. J Am Geriatr Soc. 1995;43(11):1214–21.
3. Stel VS, Smit JH, Pluijm SMF, et al. Consequences of falling in older men and women and risk factors for health service use and functional decline. Age Ageing. 2004;33(1):58–65.
4. Hartholt KA, Polinder S, Van der Cammen TJ, et al. Costs of falls in an ageing population: a nationwide study from the Netherlands (2007–2009). Injury. 2012;43(7):1199–203.
5. Roudsari BS, Ebel BE, Corso PS, et al. The acute medical care costs of fall-related injuries among the U.S. older adults. Injury. 2005;36(11):1316–22. doi:10.1016/j.injury.2005.05.024.
6. Karlsson MK, Vonschewelov T, Karlsson C, et al. Prevention of falls in the elderly: a review. Scand J Public Health. 2013;41(5):442–54.
7. Panel on Prevention of Falls in Older Persons American Geriatrics Society. British Geriatrics Society. Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc. 2011;59(1):148–57.
8. Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952–60.
9. Hartikainen S, Lönnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62(10):1172–81.
10. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc. 1999;47(1):30–9.
11. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47(1):40–50.
12. van Strien AM, Koek HL, van Marum RJ, et al. Psychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly. Maturitas. 2013;74(4):357–62.
13. Hill K, Wee R. Psychotropic drug-induced falls in older people. Drugs Aging. 2012;29(1):15–30. doi:10.2165/11598420-000000000-00000.
14. Moden B, Merlo J, Ohlsson H, et al. Psychotropic drugs and falling accidents among the elderly: a nested case control study in the whole population of Scania, Sweden. J Epidemiol Community Health. 2010;64(5):440–6.
15. van Wijngaarden JP, Dhonukshe-Rutten RA, van Schoor NM, et al. Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence. BMC Geriatr. 2011;11:80.
16. The prevention of falls in later life. A report of the Kellogg International Work Group on the Prevention of Falls by the Elderly. Dan Med Bull. 1987;34(Suppl 4):1–24.
17. ATC and DDD Index. WHO Collaborating Centre for Drug Statistics Methodology, Oslo. http://www.whocc.no/atc_ddd_index/.
18. Pincus T, Summey JA, Soraci SA Jr, et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26(11):1346–53.
19. Sjoberg C, Wallerstedt SM. Effects of medication reviews performed by a physician on treatment with fracture-preventing and fall-risk-increasing drugs in older adults with hip fracture-a randomized controlled study. J Am Geriatr Soc. 2013;61(9):1464–72.
20. Hartholt KA, Boye ND, Van der Velde N, et al. [Cost] effectiveness of withdrawal of fall-risk increasing drugs versus conservative treatment in older fallers: design of a multicenter randomized controlled trial (IMPROveFALL-study). BMC Geriatr. 2011;11:48.
21. Whitworth JA, World Health Organization ISoHWG. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21(11):1983–92.
22. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–94.
23. Swart KMA, Enneman AW, van Wijngaarden JP, et al. Homocysteine and the methylenetetrahydrofolate reductase 677C[srarr]T polymorphism in relation to muscle mass and strength, physical performance and postural sway. Eur J Clin Nutr. 2013;67(7):743–8. doi:10.1038/ejcn.2013.97.
24. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49.
25. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.
26. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.
27. Heijboer AC, Blankenstein MA, Kema IP, et al. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem. 2012;58(3):543–8.
28. Stricker BH, Stijnen T. Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies. Eur J Epidemiol. 2010;25(4):245–51.
29. Butt DA, Mamdani M, Austin PC, et al. The risk of falls on initiation of antihypertensive drugs in the elderly. Osteoporos Int. 2013;24(10):2649–57.
30. Gribbin J, Hubbard R, Gladman J, et al. Risk of falls associated with antihypertensive medication: self-controlled case series. Pharmacoepidemiol Drug Saf. 2011;20(8):879–84.
31. Gribbin J, Hubbard R, Gladman JR, et al. Risk of falls associated with antihypertensive medication: population-based case-control study. Age Ageing. 2010;39(5):592–7.
32. Lee HC, Ti Huang K, Shen WK. Use of antiarrhythmic drugs in elderly patients. J Geriatr Cardiol. 2011;8(3):184–94.
33. Volotinen M, Hakkola J, Pelkonen O, et al. Metabolism of ophthalmic timolol: new aspects of an old drug. Basic Clin Pharmacol Toxicol. 2011;108(5):297–303.
34. Nieminen T, Lehtimaki T, Maenpaa J, et al. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Scand J Clin Lab Invest. 2007;67(2):237–45.
35. Muller ME, van der Velde N, Krulder JW, et al. Syncope and falls due to timolol eye drops. BMJ. 2006;332(7547):960–1.
36. Reiter MJ. Cardiovascular drug class specificity: β-blockers. Prog Cardiovasc Dis. 2004;47(1):11–33. doi:10.1016/j.pcad.2004.04.004.
37. Haerer W, Delbaere K, Bartlett H, et al. Relationships between HMG-CoA reductase inhibitors (statin) use and strength, balance and falls in older people. Intern Med J. 2012;42(12):1329–34.
38. Macedo AF, Taylor FC, Casas JP, et al. Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. BMC Med. 2014;12(1):51.
39. Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;(1):CD004816.
40. Liamis G, Rodenburg EM, Hofman A, et al. Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med. 2013;126(3):256–63.
41. Cumming K, Hoyle GE, Hutchison JD, et al. Prevalence, incidence and etiology of hyponatremia in elderly patients with fragility fractures. PLoS One. 2014;9(2):e88272.
42. Gunathilake R, Oldmeadow C, McEvoy M, et al. Mild hyponatremia is associated with impaired cognition and falls in community-dwelling older persons. J Am Geriatr Soc. 2013;61(10):1838–9.
43. Quach L, Yang FM, Berry SD, et al. Depression, antidepressants, and falls among community-dwelling elderly people: the MOBILIZE Boston study. J Gerontol A Biol Sci Med Sci. 2013;68(12):1575–81.
44. Kvelde T, McVeigh C, Toson B, et al. Depressive symptomatology as a risk factor for falls in older people: systematic review and meta-analysis. J Am Geriatr Soc. 2013;61(5):694–706.
45. Coupland CA, Dhiman P, Barton G, et al. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Health Technol Assess. 2011;15(28):1–202 (iii-iv).
46. Gribbin J, Hubbard R, Gladman J, et al. Serotonin-norepinephrine reuptake inhibitor antidepressants and the risk of falls in older people: case-control and case-series analysis of a large UK primary care database. Drugs Aging. 2011;28(11):895–902.
47. Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;(9):CD007146.
48. Boyle N, Naganathan V, Cumming RG. Medication and falls: risk and optimization. Clin Geriatr Med. 2010;26(4):583–605.